Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PharmGKB summary: gemcitabine pathway.
Alvarellos ML, Lamba J, Sangkuhl K, Thorn CF, Wang L, Klein DJ, Altman RB, Klein TE. Alvarellos ML, et al. Pharmacogenet Genomics. 2014 Nov;24(11):564-74. doi: 10.1097/FPC.0000000000000086. Pharmacogenet Genomics. 2014. PMID: 25162786 Free PMC article. No abstract available.
PharmGKB summary: very important pharmacogene information for CYP4F2.
Alvarellos ML, Sangkuhl K, Daneshjou R, Whirl-Carrillo M, Altman RB, Klein TE. Alvarellos ML, et al. Pharmacogenet Genomics. 2015 Jan;25(1):41-7. doi: 10.1097/FPC.0000000000000100. Pharmacogenet Genomics. 2015. PMID: 25370453 Free PMC article. Review. No abstract available.
PharmGKB summary: Efavirenz pathway, pharmacokinetics.
McDonagh EM, Lau JL, Alvarellos ML, Altman RB, Klein TE. McDonagh EM, et al. Among authors: alvarellos ml. Pharmacogenet Genomics. 2015 Jul;25(7):363-76. doi: 10.1097/FPC.0000000000000145. Pharmacogenet Genomics. 2015. PMID: 25966836 Free PMC article. Review. No abstract available.
PharmGKB summary: very important pharmacogene information for RYR1.
Alvarellos ML, Krauss RM, Wilke RA, Altman RB, Klein TE. Alvarellos ML, et al. Pharmacogenet Genomics. 2016 Mar;26(3):138-44. doi: 10.1097/FPC.0000000000000198. Pharmacogenet Genomics. 2016. PMID: 26709912 Free PMC article. Review. No abstract available.
PharmGKB summary: very important pharmacogene information for CACNA1S.
Sangkuhl K, Dirksen RT, Alvarellos ML, Altman RB, Klein TE. Sangkuhl K, et al. Among authors: alvarellos ml. Pharmacogenet Genomics. 2020 Feb;30(2):34-44. doi: 10.1097/FPC.0000000000000393. Pharmacogenet Genomics. 2020. PMID: 31851124 Free PMC article.
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the Use of Potent Volatile Anesthetic Agents and Succinylcholine in the Context of RYR1 or CACNA1S Genotypes.
Gonsalves SG, Dirksen RT, Sangkuhl K, Pulk R, Alvarellos M, Vo T, Hikino K, Roden D, Klein TE, Poler SM, Patel S, Caudle KE, Gordon R, Brandom B, Biesecker LG. Gonsalves SG, et al. Clin Pharmacol Ther. 2019 Jun;105(6):1338-1344. doi: 10.1002/cpt.1319. Epub 2019 Jan 24. Clin Pharmacol Ther. 2019. PMID: 30499100 Free PMC article. Review.
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing.
Gammal RS, Court MH, Haidar CE, Iwuchukwu OF, Gaur AH, Alvarellos M, Guillemette C, Lennox JL, Whirl-Carrillo M, Brummel SS, Ratain MJ, Klein TE, Schackman BR, Caudle KE, Haas DW; Clinical Pharmacogenetics Implementation Consortium. Gammal RS, et al. Clin Pharmacol Ther. 2016 Apr;99(4):363-9. doi: 10.1002/cpt.269. Epub 2015 Nov 9. Clin Pharmacol Ther. 2016. PMID: 26417955 Free PMC article. Review.